HK Movers | Biotech Stocks Surge With JW Therap up 20%, RemeGen up 13%
Jun 24, 2025 7:37 AM
Biotech stocks surged in Hong Kong. JW Therap rose 20%; RemeGen rose 13%; Biocytogen rose 9%; Laekna rose 6%; WuXi AppTec and WuXi Biologics rose 4%.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Why the Yen Falls Further the More It Is Rescued: The Answer Lies in Japan’s Own Structural Contradictions
TradingKey - Entering early 2026, the attention of global investors is once again locked on the Japanese Yen (JPY). Despite the Bank of Japan (BoJ) gradually raising policy rates to a range of 0.5% - 0.75%, marking a definitive end to the era of negative interest rates, the yen continues to trend lower against the U.S. dollar.TradingKey
5 hours ago
What Is the Best Nuclear Energy Investment in 2026? Which Should You Buy in, OKLO or Nuclear Energy ETFs?
TradingKey - Demand for electricity is surging, and data centers designed for artificial intelligence are a big reason. Governments are also demanding cleaner, dependable power. This coupling has brought about a revival in nuclear power, with capacity expected to increase in the coming decades. To iTradingKey
9 hours ago
Stock Market Crash 2026: What Fed Signals and Economic Data Mean for Investors
TradingKey - The possibility of a stock market crash occurring in 2026 is becoming increasingly likely as investor sentiment continues to decline.TradingKey
13 hours ago
New Fed Chair Warsh Takes Office: Major Shift in Monetary Policy? US Dollar Short-Term Rebound, 2026 Investment Strategy Analysis
TradingKey - At the start of 2026, global financial markets witnessed a major leadership change as U.S. President Trump officially nominated Kevin Warsh as the next Federal Reserve Chair. Pending Senate confirmation, he will succeed Jerome Powell this May to lead the world’s most influential central bank.TradingKey
Thu, Feb 19
